Cargando…

Gastrointestinal perforation after bevacizumab: a multi-site, single-institution study with a focus on survival

BACKGROUND: Bevacizumab-induced gastrointestinal perforation is a rare but potentially devastating adverse event that has generated limited data on overall survival. Yet, such survival data are critical in guiding management. METHODS: This multi-site, single-institution retrospective study focused o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Storandt, Michael H., Tran, Nguyen H., Ehret, Christopher J., Hanna, Mina, Jochum, Jacob, Moynagh, Michael R., Jatoi, Aminah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249159/ https://www.ncbi.nlm.nih.gov/pubmed/37291587 http://dx.doi.org/10.1186/s12957-023-03058-x

Ejemplares similares

Hiccups in patients with cancer: a multi-site, single-institution study of etiology, severity, complications, interventions, and outcomes
por: Ehret, Christopher J., et al.
Publicado: (2022)

A randomized, double-blinded feasibility trial of educational materials for hiccups in chemotherapy-treated patients with cancer
por: Ehret, Christopher J., et al.
Publicado: (2022)

Should Loss of Appetite Be Palliated in Patients with Advanced Cancer?
por: Ehret, Christopher, et al.
Publicado: (2021)

Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis
por: Storandt, Michael H., et al.
Publicado: (2023)

What percentage of patients with cancer develop hiccups with oxaliplatin- or cisplatin-based chemotherapy? a compilation of patient-reported outcomes
por: Ehret, Christopher, et al.
Publicado: (2023)

Numbers Have Life: A Commentary on “Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit”
por: Le‐Rademacher, Jennifer G., et al.
Publicado: (2019)

Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation
por: Tol, J., et al.
Publicado: (2008)

Gastrointestinal Perforation With an Intraluminal Stent and Bevacizumab use in Advanced Metastatic Colorectal Cancer
por: Akeel, Nouf, et al.
Publicado: (2021)

Gastrointestinal Tract Perforation: MDCT Findings according to the Perforation Sites
por: Kim, Sung Hwan, et al.
Publicado: (2009)

MDCT Findings in Gastrointestinal Perforations and the Predictive Value according to the Site of Perforation
por: Romano, Stefania, et al.
Publicado: (2022)

Bevacizumab‐associated intestinal perforation and perioperative complications in patients receiving bevacizumab
por: Yoshimoto, Toshiaki, et al.
Publicado: (2020)

Gastrointestinal perforation: relation to corticosteroid use and COPD – a case report
por: Nguyen, Michael H.K., et al.
Publicado: (2016)

Spontaneous massive duodenal perforation after ovarian cancer treatment with bevacizumab
por: Karanikas, Michael, et al.
Publicado: (2020)

Pemetrexed for Ovarian Cancer: A Systematic Review of the Published Literature and a Consecutive Series of Patients Treated in a Nonclinical Trial Setting
por: Egloff, Heidi, et al.
Publicado: (2014)

Asphyxiation with a Fentanyl Patch
por: Mansfield, Aaron S., et al.
Publicado: (2013)

Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab
por: Adhikari, Ramesh, et al.
Publicado: (2021)

Bowel Perforation in the Emergency Department Related to Bevacizumab Therapy and Recurrent Ovarian Cancer
por: Ostby, Stuart A., et al.
Publicado: (2020)

Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab
por: Masood, Muaaz, et al.
Publicado: (2021)

Recurrent colon perforation after discontinuation of bevacizumab for ovarian cancer
por: Nonaka, Michiko, et al.
Publicado: (2018)

Patients’ rationale for declining participation in a cancer-associated weight loss study
por: Wanger, Tammy, et al.
Publicado: (2014)

Social Determinants of Health: A Need for Evidence-Based Guidelines on How to Capture Data on Underserved Patients
por: Tran, Nguyen H., et al.
Publicado: (2023)

Acute Eosinophilic Pneumonia: A Rare Complication of Daptomycin Therapy
por: Storandt, Michael H, et al.
Publicado: (2020)

Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
por: Ou, George, et al.
Publicado: (2016)

Gastrointestinal perforation: ultrasonographic diagnosis
por: Coppolino, FF, et al.
Publicado: (2013)

Endoscopic modalities for upper gastrointestinal leaks, fistulae and perforations
por: Talbot, Michael, et al.
Publicado: (2015)

Cancer therapy and cardiovascular risk: focus on bevacizumab
por: Economopoulou, Panagiota, et al.
Publicado: (2015)

Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series
por: Oliveira, Jennifer L., et al.
Publicado: (2022)

Are 5–7 Days of Folic Acid Supplementation Necessary prior to Pemetrexed? Observations from a Case Series
por: Griffin, Benjamin R., et al.
Publicado: (2013)

Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study
por: Palmer, Mathias E., et al.
Publicado: (2023)

Update and developments in the treatment of glioblastoma multiforme – focus on bevacizumab
por: Wagle, Naveed, et al.
Publicado: (2010)

Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss
por: Le‐Rademacher, Jennifer G., et al.
Publicado: (2019)

Comparison of efficacy of combination therapy of an Intravitreal injection of bevacizumab and photocoagulation versus Pan Retinal Photocoagulation alone in High risk Proliferative Diabetic Retinopathy
por: Rebecca,, et al.
Publicado: (2021)

Utilization of Circulating Tumor Cells in the Management of Solid Tumors
por: Kurniali, Peter C., et al.
Publicado: (2023)

Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients
por: Mailliez, A, et al.
Publicado: (2010)

Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer
por: Sasaki, Akinori, et al.
Publicado: (2020)

Intravitreal Bevacizumab for the Treatment of Choroidal Neovascularization after Eyeball Perforation during Retrobulbar Anesthesia
por: Kim, Kyung Won, et al.
Publicado: (2021)

Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
por: Li, Jia, et al.
Publicado: (2009)

Endotoxin and cytokines in patients with gastrointestinal tract perforation
por: Endo, S., et al.
Publicado: (1992)

Gastrointestinal Perforation in Neonates: Aetiology and Risk Factors
por: Hyginus, Ekwunife Okechukwu, et al.
Publicado: (2013)

Massive gastrointestinal perforation discovered by computed tomography
por: Miyamichi, Ryosuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_55jvfuupkjnbqvbg8244qg2550